396 related articles for article (PubMed ID: 1095296)
1. Leydig cells.
Neaves WB
Contraception; 1975 May; 11(5):571-606. PubMed ID: 1095296
[TBL] [Abstract][Full Text] [Related]
2. The influence of pharmaceutical compounds on male fertility.
Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
[TBL] [Abstract][Full Text] [Related]
3. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens.
Guerin JF; Rollet J
Int J Androl; 1988 Jun; 11(3):187-99. PubMed ID: 2970439
[TBL] [Abstract][Full Text] [Related]
5. Endogenous antispermatogenic agents: prospects for male contraception.
Ewing LL; Robaire B
Annu Rev Pharmacol Toxicol; 1978; 18():167-87. PubMed ID: 206192
[TBL] [Abstract][Full Text] [Related]
6. Developments in the control of testicular function.
Swerdloff RS; Wang C; Bhasin S
Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
[TBL] [Abstract][Full Text] [Related]
7. In vitro steroid metabolic studies in human testes I: Effects of estrogen on progesterone metabolism.
Rodriguez-Rigau LJ; Tcholakian RK; Smith KD; Steinberger E
Steroids; 1977 Jun; 29(6):771-86. PubMed ID: 910250
[TBL] [Abstract][Full Text] [Related]
8. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
10. Hormones and hormonal target cells in the testis.
Hansson V; Djoseland O; Torgersen O; Ritzen EM; French FS; Nayfeh SN
Andrologia; 1976; 8(3):195-202. PubMed ID: 187086
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives.
Johnson L; Barnard JJ; Rodriguez L; Smith EC; Swerdloff RS; Wang XH; Wang C
J Androl; 1998; 19(3):348-57. PubMed ID: 9639052
[TBL] [Abstract][Full Text] [Related]
12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
13. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
14. Germinal cell aplasia: response of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone to LH/FSH-releasing hormone with histopathologic correlation.
Guay AT; Tuthill RJ; Woolf PD
Fertil Steril; 1977 Jun; 28(6):642-9. PubMed ID: 324822
[TBL] [Abstract][Full Text] [Related]
15. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
[TBL] [Abstract][Full Text] [Related]
16. Restoration effects of exogenous luteinizing hormone on the testicular steroidogenesis and Leydig cell ultrastructure.
Wing TY; Ewing LL; Zegeye B; Zirkin BR
Endocrinology; 1985 Nov; 117(5):1779-87. PubMed ID: 4042963
[TBL] [Abstract][Full Text] [Related]
17. The effects of selective withdrawal of FSH or LH on spermatogenesis in the immature rat.
Madhwa Raj HG; Dym M
Biol Reprod; 1976 May; 14(4):489-94. PubMed ID: 819047
[TBL] [Abstract][Full Text] [Related]
18. Target sites for suppressing fertility in the male.
Prasad MR; Rajalakshmi M
Adv Sex Horm Res; 1976; 2():263-87. PubMed ID: 797248
[TBL] [Abstract][Full Text] [Related]
19. Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.
Moltz L; Römmler A; Post K; Schwartz U; Hammerstein J
Contraception; 1980 Apr; 21(4):393-413. PubMed ID: 6771095
[TBL] [Abstract][Full Text] [Related]
20. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
